🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was an exploratory proof of concept study to determine the clinical ac...
Status
Completed
Location
Antwerp University Hospital, Wilrijkstraat 10
Start Date
2012-12
Trial ID
NCT01743469
Treatments Being Tested
The standard of care for men with metastatic CRPC in 2010 following progres...
Status
Completed
Location
The University of Chicago
Start Date
2012-01
Trial ID
NCT01513733
Treatments Being Tested
This randomized phase II trial studies how well sipuleucel-T with or withou...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2015-01
Trial ID
NCT02159950
Treatments Being Tested
This study is the first study of tasquinimod, an inhibitor of S100A9, in pa...
Status
Terminated
Location
University of Pennsylvania
Start Date
2020-07-10
Trial ID
NCT04405167
Treatments Being Tested
The primary objective was to confirm the effect of tasquinimod in delaying ...
Status
Terminated
Location
Beijing Chao-Yang Hospital Capital Medical University
Start Date
2014-01
Trial ID
NCT02057666
Treatments Being Tested
The goal of this clinical trial is to learn if therapy can be improved in p...
Status
Recruiting
Location
DE-Aachen-UKAACHEN
Start Date
2025-02-20
Trial ID
NCT06605586
Treatments Being Tested
The purpose of this study is to confirm that tasquinimod used as maintenanc...
Status
Terminated
Location
AZ Maria Middelares
Start Date
2013-01
Trial ID
NCT01732549
Treatments Being Tested
To learn if tasquinimod either alone or in combination with ruxolitinib can...
Status
Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-08-01
Trial ID
NCT06327100
Treatments Being Tested
To investigate ABR-215050 as a possible treatment for prostate cancer....
Status
Completed
Location
Alaska Clinical Research Center LLC
Start Date
2007-12
Trial ID
NCT00560482
Treatments Being Tested
This is a Phase I/Ib study of Radium-223 in combination with Tasquinimod fo...
Status
Withdrawn
Location
Johns Hopkins Hospital
Start Date
2015-03
Trial ID
NCT02396368
Treatments Being Tested